Stockscreener 앱 받기
0.6031
5.54%
-0.0354
시간 외 거래:
.62
0.0169
+2.80%
전일 마감가:
$0.6385
열려 있는:
$0.6609
하루 거래량:
1.04M
Relative Volume:
0.33
시가총액:
$24.99M
수익:
$1.50M
순이익/손실:
$-64.59M
주가수익비율:
-0.3611
EPS:
-1.67
순현금흐름:
$-55.17M
1주 성능:
-21.03%
1개월 성능:
+101.98%
6개월 성능:
+86.14%
1년 성능:
-73.89%
1일 변동 폭
$0.6017
$0.67
1주일 범위
$0.6017
$0.777
52주 변동 폭
$0.2223
$4.79
립 테라퓨틱스 Stock (LPTX) Company Profile
명칭
Leap Therapeutics Inc
전화
617 252 4343
주소
47 THORNDIKE STREET, CAMBRIDGE, MA
LPTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.6031 | 36.17M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
립 테라퓨틱스 Stock (LPTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-01-29 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | 개시 | Rodman & Renshaw | Buy |
| 2021-10-04 | 개시 | Mizuho | Buy |
| 2021-06-04 | 재개 | Robert W. Baird | Outperform |
| 2020-06-29 | 개시 | Piper Sandler | Overweight |
| 2020-02-11 | 개시 | Robert W. Baird | Outperform |
| 2019-11-15 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | 재개 | Raymond James | Outperform |
| 2017-03-07 | 개시 | Ladenburg Thalmann | Buy |
모두보기
립 테라퓨틱스 주식(LPTX)의 최신 뉴스
Will Leap Therapeutics Inc. price bounce be sustainableJuly 2025 Review & Risk Controlled Stock Alerts - newser.com
How cyclical is Leap Therapeutics Inc. (5MC) stock compared to rivalsJuly 2025 EndofMonth & Reliable Price Action Trade Plans - newser.com
Will Leap Therapeutics Inc. stock outperform growth indexesJuly 2025 EndofMonth & Real-Time Market Sentiment Alerts - newser.com
Developing predictive dashboards with Leap Therapeutics Inc. dataJuly 2025 Trade Ideas & AI Powered Market Entry Ideas - newser.com
How to forecast Leap Therapeutics Inc. trends using time seriesJuly 2025 Outlook & Weekly Top Gainers Alerts - newser.com
Will Leap Therapeutics Inc. outperform the marketMarket Risk Summary & Weekly High Potential Stock Alerts - newser.com
Will Leap Therapeutics Inc. stock maintain momentum in 2025Quarterly Earnings Report & Fast Exit/Entry Strategy Plans - newser.com
Is Leap Therapeutics Inc. meeting your algorithmic filter criteria2025 Historical Comparison & Entry Point Strategy Guides - newser.com
Institutional scanner results for Leap Therapeutics Inc.July 2025 Price Swings & Reliable Breakout Forecasts - newser.com
Will Leap Therapeutics Inc. (5MC) stock sustain uptrend momentumEarnings Summary Report & Community Trade Idea Sharing - newser.com
Leap Therapeutics Closes $58.88 Million Private Placement In Cash Led by Winklevoss Capital - citybiz
Leap Therapeutics raises $58.9 million for digital asset strategy By Investing.com - Investing.com Canada
Is Leap Therapeutics Inc. (5MC) stock vulnerable to rate hikesWeekly Volume Report & Capital Protection Trade Alerts - newser.com
Leap Therapeutics closes $58.9 million funding led by Winklevoss Capital - Investing.com Canada
$58.9M Raise: Leap Therapeutics and Winklevoss Capital to Build Digital Asset Treasury; Board Expanded - Stock Titan
Will Leap Therapeutics Inc. (5MC) stock profit from fiscal stimulusPortfolio Return Report & Stepwise Swing Trade Plans - newser.com
How interest rate cuts could boost Leap Therapeutics Inc. stockJuly 2025 Momentum & Free High Return Stock Watch Alerts - newser.com
Leap Therapeutics secures $58.9M PIPE to launch digital asset strategy; shares up 29% - MSN
Leap Therapeutics Granted Extension by Nasdaq - MSN
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion - MarketScreener
Why Is Leap Therapeutics Down 9% In Pre-Market Trading? - Benzinga
Leap Therapeutics: Blending Biotech and Blockchain - OneSafe
Leap Therapeutics (LPTX) Stock: Soars 58% After $58.9M PIPE Deal with Winklevoss Capital to Launch Crypto Treasury - CoinCentral
Winklevoss-Backed Leap Therapeutics to Start Crypto Treasury - The Crypto Times
Leap Therapeutics (LPTX) Stock Jumps on $58M Winklevoss-Led Crypto Deal - parameter.io
Leap Therapeutics Announces $58.88M Private Placement Led by Winklevoss Capital - citybiz
Leap Therapeutics stock soars after securing $58.9M investment By Investing.com - Investing.com
Biotech Goes Bitcoin: Leap Therapeutics Surges 29% on Groundbreaking Crypto Treasury Deal with Winklevoss Capital - FinancialContent
Leap Therapeutics Gains 25% on Crypto Deal - CoinDesk
Leap Therapeutics (LPTX) Secures $58.9M Financing for Growth Ini - GuruFocus
Leap Therapeutics (LPTX) Announces Strategic Investment and Boar - GuruFocus
Leap therapeutics secures $58.9 million for digital asset strategy By Investing.com - Investing.com Canada
Leap Therapeutics raises $58.9M in private placement for digital assets - Investing.com Canada
Leap therapeutics secures $58.9 million for digital asset strategy - Investing.com India
Leap Therapeutics Surges on Winklevoss-Led Cash Boost for Crypto Treasury Gamble - RagingBull
$58.9M Raise: Leap Therapeutics Starts Digital Asset Treasury; Winklevoss to Nominate Two Board Members - Stock Titan
Can volume confirm reversal in Leap Therapeutics Inc.2025 Price Action Summary & Safe Entry Zone Tips - newser.com
Reversal indicators forming on Leap Therapeutics Inc. stock2025 Breakouts & Breakdowns & Technical Pattern Based Signals - newser.com
Published on: 2025-10-06 03:41:46 - newser.com
Will Leap Therapeutics Inc. (5MC) stock remain on Wall Street radarWall Street Watch & Reliable Intraday Trade Alerts - newser.com
Heatmap analysis for Leap Therapeutics Inc. and competitorsTake Profit & Verified Momentum Stock Ideas - newser.com
Is Leap Therapeutics Inc. (5MC) stock cheap vs fundamentalsPortfolio Profit Report & Free Community Consensus Stock Picks - newser.com
Published on: 2025-10-05 02:35:13 - newser.com
Leap Therapeutics (LPTX) Plummets Over 20% Amidst Profit-Taking and Volatility Ahead of Key Clinical Data - FinancialContent
What consensus target says about Leap Therapeutics Inc. (5MC) stockWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Is now a turning point for Leap Therapeutics Inc.Weekly Volume Report & Growth Focused Investment Plans - newser.com
립 테라퓨틱스 (LPTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.11%
자본화:
|
볼륨(24시간):